End-of-day quote
Taipei Exchange
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
37.9
TWD
|
+0.53%
|
|
+7.21%
|
+18.07%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,777
|
1,114
|
1,237
|
1,050
|
739.4
|
827
|
Enterprise Value (EV)
1 |
1,531
|
902.5
|
1,042
|
797.6
|
607.2
|
815
|
P/E ratio
|
-94.3
x
|
-21.2
x
|
-19.5
x
|
43.8
x
|
-6.72
x
|
-45.1
x
|
Yield
|
-
|
-
|
-
|
0.49%
|
-
|
-
|
Capitalization / Revenue
|
8.24
x
|
6.79
x
|
8.14
x
|
56
x
|
31.8
x
|
12.6
x
|
EV / Revenue
|
7.09
x
|
5.5
x
|
6.86
x
|
42.5
x
|
26.1
x
|
12.5
x
|
EV / EBITDA
|
-33.7
x
|
-10.4
x
|
-33.6
x
|
-21.6
x
|
-19
x
|
-39.2
x
|
EV / FCF
|
-23.2
x
|
-34.5
x
|
47.7
x
|
97.9
x
|
-23
x
|
273
x
|
FCF Yield
|
-4.32%
|
-2.9%
|
2.1%
|
1.02%
|
-4.35%
|
0.37%
|
Price to Book
|
4.57
x
|
3.31
x
|
4.53
x
|
3.54
x
|
4.06
x
|
5.05
x
|
Nbr of stocks (in thousands)
|
25,763
|
25,763
|
25,763
|
25,763
|
25,763
|
25,763
|
Reference price
2 |
68.99
|
43.26
|
48.02
|
40.75
|
28.70
|
32.10
|
Announcement Date
|
2/21/19
|
3/18/20
|
3/16/21
|
3/11/22
|
3/6/23
|
3/12/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
215.7
|
164
|
152.1
|
18.75
|
23.23
|
65.41
|
EBITDA
1 |
-45.37
|
-86.49
|
-30.99
|
-36.92
|
-31.98
|
-20.8
|
EBIT
1 |
-45.71
|
-86.89
|
-31.3
|
-37.59
|
-32.45
|
-21.19
|
Operating Margin
|
-21.19%
|
-52.97%
|
-20.58%
|
-200.52%
|
-139.67%
|
-32.39%
|
Earnings before Tax (EBT)
1 |
-16.26
|
-62
|
-55.42
|
27.72
|
-109.3
|
-19.14
|
Net income
1 |
-18.68
|
-52.62
|
-63.4
|
24.04
|
-110.1
|
-18.33
|
Net margin
|
-8.66%
|
-32.08%
|
-41.7%
|
128.24%
|
-473.86%
|
-28.02%
|
EPS
2 |
-0.7313
|
-2.043
|
-2.461
|
0.9300
|
-4.273
|
-0.7115
|
Free Cash Flow
1 |
-66.11
|
-26.18
|
21.85
|
8.15
|
-26.39
|
2.98
|
FCF margin
|
-30.65%
|
-15.96%
|
14.37%
|
43.47%
|
-113.59%
|
4.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
33.9%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.2000
|
-
|
-
|
Announcement Date
|
2/21/19
|
3/18/20
|
3/16/21
|
3/11/22
|
3/6/23
|
3/12/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
247
|
212
|
195
|
252
|
132
|
12
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-66.1
|
-26.2
|
21.8
|
8.15
|
-26.4
|
2.98
|
ROE (net income / shareholders' equity)
|
-4.45%
|
-14.5%
|
-20.8%
|
8.44%
|
-46%
|
-10.4%
|
ROA (Net income/ Total Assets)
|
-6.34%
|
-12.3%
|
-4.84%
|
-5.76%
|
-5.74%
|
-4.42%
|
Assets
1 |
294.9
|
427.3
|
1,311
|
-417.1
|
1,919
|
414.4
|
Book Value Per Share
2 |
15.10
|
13.10
|
10.60
|
11.50
|
7.060
|
6.350
|
Cash Flow per Share
2 |
2.120
|
1.260
|
1.660
|
3.380
|
1.510
|
1.350
|
Capex
1 |
0.53
|
-
|
0.43
|
0.1
|
1.05
|
-
|
Capex / Sales
|
0.25%
|
-
|
0.28%
|
0.55%
|
4.52%
|
-
|
Announcement Date
|
2/21/19
|
3/18/20
|
3/16/21
|
3/11/22
|
3/6/23
|
3/12/24
|
|
1st Jan change
|
Capi.
|
---|
| +18.07% | 30.21M | | +17.57% | 8.47B | | +3.37% | 7.6B | | +5.65% | 6.26B | | -4.57% | 3.78B | | -6.87% | 3.73B | | -2.14% | 1.35B | | -26.41% | 1.12B | | +15.61% | 998M | | -7.15% | 948M |
Special Foods & Wellbeing Products
|